Chronic Rhinitis
34
4
8
18
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
11.8%
4 terminated out of 34 trials
81.8%
-4.8% vs benchmark
6%
2 trials in Phase 3/4
50%
9 of 18 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 18 completed trials
Clinical Trials (34)
The Epidemiological and Intrinsic Characteristics of Chronic Rhinitis
Efficacy and Safety of High-Concentration 35 kDa Hyaluronan Gel for Chronic Nasopharyngitis
Inhaled vs Intranasal Corticosteroids for Chronic Cough in Upper Airway Cough Syndrome
Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis (CLARITY)
NEUROMARK Registry Study
A Randomized Controlled Trial Comparing Posterior Nasal Nerve Ablation Procedures for Chronic Rhinitis
Clinical Evaluation of Safety and Efficacy for the NEUROMARK System in Subjects With Chronic Rhinitis (PARAGON)
Traditional vs. Posterior Nasal Radiofrequency Ablation for Chronic Rhinitis
Evaluation of Pulsed Field Ablation of the Posterior Nasal Nerve for Chronic Rhinitis
Steroid Treatment for Elimination of Rebound Obstruction From Intranasal Decongestants
NEUROMARK Randomized Controlled Trial
A Study of RhinAer Stylus for Treating Chronic Rhinitis
Laser Posterior Nasal Nerve Neurolysis
A Study of RhinAer ARC Stylus for Treating Chronic Rhinitis (RELIEF)
Study on the Optimization of the Diagnostic Process for Chronic Rhinitis Using Nasal Allergen Provocation Test
RhinAer Procedure for Treatment of Chronic Rhinitis Study
Effects of Radiofrequency Ablation of Posterior Nasal Nerves on Inflammatory Cytokines, Peak Nasal Inspiratory Flow, and Nasal Blood Flow in Patients With Chronic Rhinitis
ClariFix Rhinitis RCT
Diagnostic Efficacy of CDA Nasal Provocation Test in Patients With IR
Characteristic Transcriptomic, Proteomic and Metabolomic Molecular Studies of Nasal Secretions From Chronic Rhinitis